The Bacillus thuringiensis ␦-endotoxins Cry1C and Cry1E share toxicity against several important lepidopteran species. Their combined use to delay development of resistance in target insects depends on their differential interaction with the gut epithelial cells. The three structural domains and combinations of two consecutive domains of Cry1C and Cry1E were separately expressed in Escherichia coli, and their interactions with the brush border membrane vesicles (BBMV) of Cry1E-tolerant and -susceptible Spodoptera littoralis larvae were studied. About 80% reduction in binding of Cry1E and each of its separate domains to BBMV of Cry1E-tolerant larvae was observed, whereas Cry1C was toxic to all larvae and bound equally to BBMV derived from both Cry1E-tolerant and -susceptible larvae. Cry proteins are produced and assembled as heterologous crystalline bodies during sporulation of Bacillus thuringiensis. Usually Cry proteins display a narrow, specific spectrum of insecticidal activity. Cry1C is an effective insecticide against about 35-40 species and differs in its insecticidal host range from the three Cry1A toxins. Among the Cry1C-sensitive lepidopteran species, some are also sensitive to Cry1E, which has been considered as a potential alternative to avoid evolution of resistance due to intensively used Cry1C either as a component of bacterial formulations or as a transgenic plant protein (1).The N-terminal toxic parts of Cry1C and Cry1E are composed of three structural domains found to be highly similar in Cry1, Cry2, and Cry3 proteins (2-4). Domain I is composed of seven ␣-helices and is involved in ion channel formation. The -sheets comprising domain II and domain III are involved in specific interaction(s) with membrane receptors of the larval midgut epithelium, leading to the insertion into the membrane of domain I amphipathic ␣ 4 and ␣ 5 and their connecting loop. It is assumed that ␣ 4 -␣ 5 pairs from at least 4 toxin molecules are assembled to form a lethal nonselective ion channel (5-8). Insertion is also linked to the spreading of the other domain I ␣-helices over the membrane (6, 9, 10). Oligomer formation may occur prior to the insertion of ␣-helices assisted by an earlier interaction with a membrane receptor as was recently shown for the interaction of cadherin-like Bt-R1 receptor with Cry1Ab (11). Domain II loops are the least homologous parts and extend beyond the -sheet core surface (3). Introduced changes/mutations in these loops affect toxin binding and specificity (12)(13)(14)(15). Domain III is considered to be involved in both correct folding of the whole active toxin and receptor recognition. A specific site, only present in Cry1Ac domain III (amino acid residues 503-525), is responsible for the initial interaction with the N-acetylgalactosamine moiety of the aminopeptidase N (APN) 1 receptor (16). The rest of the domain III amino acid sequence is highly homologous among Cry1 proteins (13). Mutations or differences in the structural loops of Cry1C domain II (C-II) as well as domain III (C-I...